Researchers have highlighted the need for greater public health messaging around the risks of cannabis use disorders.
Early economic analysis suggests that at the right price point, cannabis-based medicines could offer a cost-effective alternative for chronic pain.
It is the first randomised trial to examine how legal, commercially available cannabis impacts anxiety symptoms.
A notable reduction in crystal meth use was observed among those who used cannabis for craving management.
A cannabis extract has shown positive results in slowing down melanoma cell growth.
In a new study, 38% of dog owners surveyed reported giving their pups cannabinoids, with 77% reporting at least some 'positive effect'.
Catch up on the latest cannabis science.
The findings have cast doubt over any potential expansion of the Medical Cannabis Access Programme (MCAP).
Researchers at LVR University Hospital Essen in Germany have announced the results of a new study on the efficacy of medical cannabis in treating chronic depression....
The study is said to 'lay the foundations' for for further research to explore cannabis as a treatment for Long COVID symptoms.
